This is an odd proposal.
Most importantly: we need to start treating drug addiction, and long term pain, as the public health emergencies they are and we need to stop criminalising drug addicts.
> Diversion investigations involve, but are not limited to, practitioners and mid-level practitioners who write prescriptions for no legitimate medical need and/or outside the scope of legitimate medical practice, or sell prescriptions to drug dealers or abusers; pharmacists who falsify records and subsequently sell or abuse the drugs; pharmacists who fill prescriptions that they knew or should have known were illegitimate; employees who steal from inventory and falsify records to cover illicit sales; prescription forgers; and individuals who commit armed robbery of
pharmacies and drug distributors
The US does massively over-prescribe opioids. There have been doctors who were careless in who they prescribed to. There have been "pill mills" https://www.theguardian.com/us-news/2019/oct/02/opioids-west...
But they don't need patient ID to track that down. They can use supplier data.
I'm also struggling to read the document. It's written in a specific, jargon heavy, way. Use of the word "subpoena" every time they mention patient data is a little bit reassuring, but it's still not great.
> CLIN 2001 Unlimited access to patient de-identified data, to be identified via subpoena, for class 2 to 5 prescription data which includes pharmacy, medical, and dental data. Fixed price per license per month
I'm still ploughing through the 60 pages to try to get my head around it.
Most importantly: we need to start treating drug addiction, and long term pain, as the public health emergencies they are and we need to stop criminalising drug addicts.
> Diversion investigations involve, but are not limited to, practitioners and mid-level practitioners who write prescriptions for no legitimate medical need and/or outside the scope of legitimate medical practice, or sell prescriptions to drug dealers or abusers; pharmacists who falsify records and subsequently sell or abuse the drugs; pharmacists who fill prescriptions that they knew or should have known were illegitimate; employees who steal from inventory and falsify records to cover illicit sales; prescription forgers; and individuals who commit armed robbery of pharmacies and drug distributors
The US does massively over-prescribe opioids. There have been doctors who were careless in who they prescribed to. There have been "pill mills" https://www.theguardian.com/us-news/2019/oct/02/opioids-west...
But they don't need patient ID to track that down. They can use supplier data.
I'm also struggling to read the document. It's written in a specific, jargon heavy, way. Use of the word "subpoena" every time they mention patient data is a little bit reassuring, but it's still not great.
> CLIN 2001 Unlimited access to patient de-identified data, to be identified via subpoena, for class 2 to 5 prescription data which includes pharmacy, medical, and dental data. Fixed price per license per month
I'm still ploughing through the 60 pages to try to get my head around it.